Articles
AI: The next frontier of innovation in life sciences
ProductLife Group’s Marco Anelli looks at the potential of artificial intelligence to change the way life sciences organisations operate. From discovery and development and throughout the entire product life cycle, artificial intelligence (AI) has already shaken up the life sciences industry by way of innovations such as AI-enabled drugs expected to be brought to market in the near future. But AI has the potential to go beyond that. Given the plethora of data all across the life sciences value chain, the ability to gather, manage, and effectively use intelligence from that data has posed a challenge. AI offers the chance to exploit the data in both structured and unstructured forms. Data that previously was hard to access or too difficu…
ProductLife Group’s Marco Anelli looks at the potential of artificial intelligence to change the way life sciences organisations operate. From discovery and development and throughout the entire product life cycle, artificial intelligence (AI) has already shaken up the life sciences industry by way of innovations such as AI-enabled drugs expected to be brought to market in the near future. But AI has the potential to go beyond that. Given the plethora of data all across the life sciences value chain, the ability to gather, manage, and effectively use intelligence from that data has posed a challenge. AI offers the chance to exploit the data in both structured and unstructured forms. Data that previously was hard to access or too difficu…
Master data management and addressing the forthcoming ISO IDMP standards
AMPLEXOR’s Sonia Monahan looks at what is involved in practice and how can life sciences firms ensure the investment pays off ISO IDMP compliance is more than just another regulatory hurdle for life sciences firms to straddle. It also promotes the kind of structure and discipline needed if organisations want to break new ground and take their businesses forward. It all begins with data though, and with assumptions about its quality, completeness, and reliability as an accurate record of operations.As EMA’s IDMP requirements near finalisation, the scale of the standards’ impact on managing regulatory data becomes more apparent. The transition from the current xEVMPD submission requirement to the more extensive and round…
AMPLEXOR’s Sonia Monahan looks at what is involved in practice and how can life sciences firms ensure the investment pays off ISO IDMP compliance is more than just another regulatory hurdle for life sciences firms to straddle. It also promotes the kind of structure and discipline needed if organisations want to break new ground and take their businesses forward. It all begins with data though, and with assumptions about its quality, completeness, and reliability as an accurate record of operations.As EMA’s IDMP requirements near finalisation, the scale of the standards’ impact on managing regulatory data becomes more apparent. The transition from the current xEVMPD submission requirement to the more extensive and round…
04-Sep-2017
This Salary Survey is jointly run by SciPro and PharmiWeb.
PharmiWeb have teamed up with SciPro to run the 2017 Salary & Trends Survey. By taking part in this survey. Take Part Today!
PharmiWeb have teamed up with SciPro to run the 2017 Salary & Trends Survey. By taking part in this survey. Take Part Today!
5 Reasons Why Pharmaceutical Companies Should Use Accredited Calibration Labs
Instruments in pharmaceutical companies should be calibrated so that their performance and results can be trusted. There should be no shred of doubt if the equipment has been calibrated as per the required standards or not. This is why you must use an accredited calibration lab for your equipment calibration.Pharmaceutical companies cannot afford to be lenient about calibration or compromise on the quality. Any kind of inaccurate measurement can cause a breach of process, product recall or potential fines from the FDA. Moreover, the user’s life could be put at risk. Even if there is a small variance, you can be subjected to large cost over-runs and a dip in the quality. To avoid such issues, you must use calibrati…
Instruments in pharmaceutical companies should be calibrated so that their performance and results can be trusted. There should be no shred of doubt if the equipment has been calibrated as per the required standards or not. This is why you must use an accredited calibration lab for your equipment calibration.Pharmaceutical companies cannot afford to be lenient about calibration or compromise on the quality. Any kind of inaccurate measurement can cause a breach of process, product recall or potential fines from the FDA. Moreover, the user’s life could be put at risk. Even if there is a small variance, you can be subjected to large cost over-runs and a dip in the quality. To avoid such issues, you must use calibrati…
04-Aug-2017
AMPLEXOR’s Romuald Braun looks at best practice in labelling management and master data management
For some life sciences firms, product labelling is treated as a distinct, manually-driven process. This is a major error and can leave them vulnerable to risk, such as costly product recalls, and inefficiency. To reduce this risk, associated processes need to be systematically managed, using automation - so that the latest compliant wording, symbols and other criteria are used consistently and reliably, and that checks and controls aren’t reliant on human proofing alone.While many organisations still rely too much on manual processes, intensifying regulatory requirements and the evolution towards IDMP means that they are looking again at their processes and systems for managing content. The mo…
For some life sciences firms, product labelling is treated as a distinct, manually-driven process. This is a major error and can leave them vulnerable to risk, such as costly product recalls, and inefficiency. To reduce this risk, associated processes need to be systematically managed, using automation - so that the latest compliant wording, symbols and other criteria are used consistently and reliably, and that checks and controls aren’t reliant on human proofing alone.While many organisations still rely too much on manual processes, intensifying regulatory requirements and the evolution towards IDMP means that they are looking again at their processes and systems for managing content. The mo…
27-Jul-2017
The use of drones in the emergency services
Care in the air - it’s what has already saved thousands of lives through the Air Ambulance service and now drones are having their moment. According to Wired, police across Devon and Cornwall have started to introduce a 24-hour drone unit: 'The drones will largely be used for surveillance of crime scenes and to help in the search for missing people, and it will be the first 24-hour drone unit in the UK, operating out of nine police stations,' stated the article.It’s vital to the Devonshire and Cornwall police that the drones protect people without being obstructive of their privacy. So far, they have been well received as a good alternative to police trying to make their way across tricky landscapes by vehicles. Due to cuts to police budgets, it’s…
Care in the air - it’s what has already saved thousands of lives through the Air Ambulance service and now drones are having their moment. According to Wired, police across Devon and Cornwall have started to introduce a 24-hour drone unit: 'The drones will largely be used for surveillance of crime scenes and to help in the search for missing people, and it will be the first 24-hour drone unit in the UK, operating out of nine police stations,' stated the article.It’s vital to the Devonshire and Cornwall police that the drones protect people without being obstructive of their privacy. So far, they have been well received as a good alternative to police trying to make their way across tricky landscapes by vehicles. Due to cuts to police budgets, it’s…
Neo4j’s Emil Eifrem takes a look at how life science researchers can use graph databases to get granular insight from big data and make real advances in research
Big data, defined as large complex data sets, has the potential to throw light onto every link in the life sciences value chain, which is why data mining has become so important to researchers – but having the right technology is key to its success. Traditional database tools, namely SQL and relational database technology, find the volume as well as the unstructured nature of these complex datasets extremely difficult to work with. Why? Because they model the world as a set of tables and columns, peppered with complex joins as the data becomes more inter-connected. Data queries are technically difficult and notoriously expensive t…
Big data, defined as large complex data sets, has the potential to throw light onto every link in the life sciences value chain, which is why data mining has become so important to researchers – but having the right technology is key to its success. Traditional database tools, namely SQL and relational database technology, find the volume as well as the unstructured nature of these complex datasets extremely difficult to work with. Why? Because they model the world as a set of tables and columns, peppered with complex joins as the data becomes more inter-connected. Data queries are technically difficult and notoriously expensive t…
Competitive intelligence gained via primary research is one of the frequently utilised decision-making aids. Most competitive intelligence firms claim to provide actionable insights. However, truly actionable insights come from credible sources of intelligence. Paying attention to the sources and respondents is vital for leveraging intelligence and its subsequent use in decision making.
The insights gathered from competitive intelligence (CI) engagements are intelligence not data, thus CI based insights are not amenable to most quantitative methods. Consequently, it is crucial to be vigilant about the quality of intelligence. In one recent survey, we found that over 80% of the intelligence comes from KOLs (Key Opinion Leader) or their associates. Further analysis revealed that nearly 75% of…
The insights gathered from competitive intelligence (CI) engagements are intelligence not data, thus CI based insights are not amenable to most quantitative methods. Consequently, it is crucial to be vigilant about the quality of intelligence. In one recent survey, we found that over 80% of the intelligence comes from KOLs (Key Opinion Leader) or their associates. Further analysis revealed that nearly 75% of…
The life sciences sector is both fascinating and diverse focusing on a wide range of subjects including biology, botany, zoology, microbiology and biochemistry. There are many different job roles available within the field too, with specialist recruiters such as NESGT filling skilled positions, but is the life sciences industry one of the best industries to be involved with?
The life sciences sector is both fascinating and diverse focusing on a wide range of subjects including biology, botany, zoology, microbiology and biochemistry. There are many different job roles available within the field too, with specialist recruiters such as NESGT filling skilled positions, but is the life sciences industry one of the best industries to be involved with?Productivity double that of national averageW…
The life sciences sector is both fascinating and diverse focusing on a wide range of subjects including biology, botany, zoology, microbiology and biochemistry. There are many different job roles available within the field too, with specialist recruiters such as NESGT filling skilled positions, but is the life sciences industry one of the best industries to be involved with?Productivity double that of national averageW…
12-Jun-2017
The UK currently accounts for the country with the highest volume of Contract Research Organization (CRO) vacancies in Europe. In this CRO report, our partners Vacancysoft have based the data from a total of 15,702 vacancies in the period between May 2015 and April 2017.
Clinical Professionals Industry Analytical Reports regularly review the life science industry, giving unique insight into the current trends. At Clinical Professionals we aim to be aware of the latest industry events and news whilst also aspiring to be at the forefront of the latest analysis and reporting. This enables us to provide concise and top notch quality service for both our clients and our candidates. Whilst helping the industry to evolve and progress as a whole. Consequently Clinical Professionals are happy to…
Clinical Professionals Industry Analytical Reports regularly review the life science industry, giving unique insight into the current trends. At Clinical Professionals we aim to be aware of the latest industry events and news whilst also aspiring to be at the forefront of the latest analysis and reporting. This enables us to provide concise and top notch quality service for both our clients and our candidates. Whilst helping the industry to evolve and progress as a whole. Consequently Clinical Professionals are happy to…
Competitive intelligence gained via primary research is one of the frequently utilised decision-making aids. Most competitive intelligence firms claim to provide actionable insights. However, truly actionable insights come from credible sources of intelligence. Paying attention to the sources and respondents is vital for leveraging intelligence and its subsequent use in decision making.
The insights gathered from competitive intelligence (CI) engagements are intelligence not data, thus CI based insights are not amenable to most quantitative methods. Consequently, it is crucial to be vigilant about the quality of intelligence. In one recent survey, we found that over 80% of the intelligence come from KOLs (Key Opinion Leader) or their associates. Further analysis revealed that nearly 75% of…
The insights gathered from competitive intelligence (CI) engagements are intelligence not data, thus CI based insights are not amenable to most quantitative methods. Consequently, it is crucial to be vigilant about the quality of intelligence. In one recent survey, we found that over 80% of the intelligence come from KOLs (Key Opinion Leader) or their associates. Further analysis revealed that nearly 75% of…
From slow start to rapid digitization: How IoT will transform the life sciences and healthcare supply chain
By Scott Allison, President, Life Sciences & Healthcare Sector, DHL Customer Solutions & Innovation The life sciences and healthcare industry as a whole has been slow to digitize. But things are starting to change now, fast-tracked by the growing phenomenon of the Internet of Things (IoT). We are told that by 2020, more than 50 billion objects will be connected to the Internet (Cisco Consulting). So far, an absence of agreed industry standards and some genuine security concerns have restricted IoT innovation. But today there is clear evidence of an upswing in industry-specific applications, and it is only a matter of time before pharmaceutical and medical device compani…
By Scott Allison, President, Life Sciences & Healthcare Sector, DHL Customer Solutions & Innovation The life sciences and healthcare industry as a whole has been slow to digitize. But things are starting to change now, fast-tracked by the growing phenomenon of the Internet of Things (IoT). We are told that by 2020, more than 50 billion objects will be connected to the Internet (Cisco Consulting). So far, an absence of agreed industry standards and some genuine security concerns have restricted IoT innovation. But today there is clear evidence of an upswing in industry-specific applications, and it is only a matter of time before pharmaceutical and medical device compani…
Working in the healthcare industry: How it’s evolved
When the NHS was founded back in July 1948, the dream was that Britain could provide healthcare for everyone at no cost to the patient. This belief is still at the forefront of the NHS with the central principles that the health service will be available to all and financed entirely from taxation. This model has worked well, but shortages of healthcare staff and increasing numbers of people who require medical care going up, mean the healthcare system often receives negative press. The Royal College of Nursing says that England is in need of at least 20,000 extra nursing staff this year, meaning at present there are 8.8 nurses per 1000 people across the UK. These figures are slightly lower for midwives, general practitioners and doctors…
When the NHS was founded back in July 1948, the dream was that Britain could provide healthcare for everyone at no cost to the patient. This belief is still at the forefront of the NHS with the central principles that the health service will be available to all and financed entirely from taxation. This model has worked well, but shortages of healthcare staff and increasing numbers of people who require medical care going up, mean the healthcare system often receives negative press. The Royal College of Nursing says that England is in need of at least 20,000 extra nursing staff this year, meaning at present there are 8.8 nurses per 1000 people across the UK. These figures are slightly lower for midwives, general practitioners and doctors…
Unless companies improve their use and manage data, they can’t hope to become more flexible, innovative or efficient, warns AMPLEXOR’S senior life sciences consultant, Siniša Belina.
Unless companies improve their use and manage data, they can’t hope to become more flexible, innovative or efficient, warns AMPLEXOR’S senior life sciences consultant, Siniša Belina. When markets as conservative and compliance oriented as banking and healthcare are being disrupted, it stands to reason that life sciences cannot afford to rest on its laurels. Whatever red tape it is shackled by, it too must heed the call to become more agile and innovative – able to respond to changing market demands. But there is a major sticking point: data. In the industries being disrupted, this has provided the key to new…
Unless companies improve their use and manage data, they can’t hope to become more flexible, innovative or efficient, warns AMPLEXOR’S senior life sciences consultant, Siniša Belina. When markets as conservative and compliance oriented as banking and healthcare are being disrupted, it stands to reason that life sciences cannot afford to rest on its laurels. Whatever red tape it is shackled by, it too must heed the call to become more agile and innovative – able to respond to changing market demands. But there is a major sticking point: data. In the industries being disrupted, this has provided the key to new…
If the life sciences industry has to raise its game in pharmacovigilance, it may as well make it pay—especially if new diligence turns up product safety as a potential market differentiator, says Cheryl Key, head of PV platform services at ProductLife Group.
If the life sciences industry has to raise its game in pharmacovigilance, it may as well make it pay—especially if new diligence turns up product safety as a potential market differentiator, says Cheryl Key, head of PV platform services at ProductLife Group.To many pharma firms, the call to innovate means giving the go-ahead to ambitious new development projects or becoming more acquisitive. Yet it could be that a company’s commitment to safety and a company’s ability to demonstrate its superiority already offer an edge the company…
If the life sciences industry has to raise its game in pharmacovigilance, it may as well make it pay—especially if new diligence turns up product safety as a potential market differentiator, says Cheryl Key, head of PV platform services at ProductLife Group.To many pharma firms, the call to innovate means giving the go-ahead to ambitious new development projects or becoming more acquisitive. Yet it could be that a company’s commitment to safety and a company’s ability to demonstrate its superiority already offer an edge the company…
Excelling in biosimilars requires robust knowledge of the landscape and monitoring of the evolving market. Apart from the usual competitive intelligence such as competitors' activities, timelines, differentiation strategies, manufacturing capabilities, sales and marketing plans etc., factoring-in overarching holistic perspective allows one to make strategically aligned and robust decisions.
Myriad of economic and patients’ benefits arguments could be made for making the widespread use of biosimilars. At a macro level, the pharma industry, in the context of biologics drugs is divided into novel and biosimilars makers. However, there are several novel companies that seek to bring biosimilars to market. The rationale for such a strategy is justified by the existence of synergy. The company mig…
Myriad of economic and patients’ benefits arguments could be made for making the widespread use of biosimilars. At a macro level, the pharma industry, in the context of biologics drugs is divided into novel and biosimilars makers. However, there are several novel companies that seek to bring biosimilars to market. The rationale for such a strategy is justified by the existence of synergy. The company mig…
01-Feb-2017
Attendance Allowance: Could you Be Claiming?
Do you have care or disability needs? Well, if so, you’ll be aware that having a disability comes at a cost. Paying for carers or any form of assistance can be expensive, but the good news is that there are many benefits available to help you manage the extra cost of having a disability or illness. Many of these benefits aren’t affected by the amount of income you earn, or the savings you have, and that’s true for attendance allowance too.But what is attendance allowance, and could you be entitled to it? Read on to find out...What is attendance allowance? Attendance allowance is a sum of money that’s available to people over 65 years old who need help with personal care. ‘Personal care’ means help with washing, dressing or eating for instance, an…
Do you have care or disability needs? Well, if so, you’ll be aware that having a disability comes at a cost. Paying for carers or any form of assistance can be expensive, but the good news is that there are many benefits available to help you manage the extra cost of having a disability or illness. Many of these benefits aren’t affected by the amount of income you earn, or the savings you have, and that’s true for attendance allowance too.But what is attendance allowance, and could you be entitled to it? Read on to find out...What is attendance allowance? Attendance allowance is a sum of money that’s available to people over 65 years old who need help with personal care. ‘Personal care’ means help with washing, dressing or eating for instance, an…
22-Dec-2016
Stuart Britton provides an SEC Recruitment perspective on what the business has seen from pharmaceutical industry employers since the Brexit vote.
Stuart Britton, CEO of SEC Recruitment, provides a pharmaceutical recruiter's perspective on what SEC Recruitment has seen in the industry since the decision to leave the UK was made by the British public. When the announcement came through on 24th June 2016 that the UK public had voted to leave the European Union, my first reaction was to think of the people we have within SEC. We’re a multi-cultural business, speaking over 20 different languages and I knew that there would be some anxiety about what the future holds for individuals. So my immediate response was to communicate with the SEC team and tell them that whilst there would be a lot of n…
Stuart Britton, CEO of SEC Recruitment, provides a pharmaceutical recruiter's perspective on what SEC Recruitment has seen in the industry since the decision to leave the UK was made by the British public. When the announcement came through on 24th June 2016 that the UK public had voted to leave the European Union, my first reaction was to think of the people we have within SEC. We’re a multi-cultural business, speaking over 20 different languages and I knew that there would be some anxiety about what the future holds for individuals. So my immediate response was to communicate with the SEC team and tell them that whilst there would be a lot of n…
19-Jul-2022
From the development of new drugs to the innovation of beyond-the-pill services and cutting-edge technology, the pharmaceutical industry has been successful in expanding its horizons in order to meet the demands of its consumers and cater to the unique needs of several patients around the globe.
From the development of new drugs to the innovation of beyond-the-pill services and cutting-edge technology, the pharmaceutical industry has been successful in expanding its horizons in order to meet the demands of its consumers and cater to the unique needs of several patients around the globe. These advancements in the field of pharmacy have significantly reshaped the current health care landscape, thereby bringing noteworthy benefits to its stakeholders. All of which are influenced by certain fa…
From the development of new drugs to the innovation of beyond-the-pill services and cutting-edge technology, the pharmaceutical industry has been successful in expanding its horizons in order to meet the demands of its consumers and cater to the unique needs of several patients around the globe. These advancements in the field of pharmacy have significantly reshaped the current health care landscape, thereby bringing noteworthy benefits to its stakeholders. All of which are influenced by certain fa…
Life sciences cannot escape the call to transform itself as other industries have had to, warns Elvis Pacelat, Vice-President of Compliance Management at AMPLEXOR
Industries from retail to financial services have long accepted the need to digitally transform their operations. It paves the way for step changes in how brands operate, how they engage and get closer to customers, how they build market feedback into development cycles, how they drive new and repeat business, and how they identify and address new market opportunities.All of these challenges exist in the pharma industry too, so it seems surprising that companies here haven’t embraced the trend more enthusiastically.One of the biggest issues life sciences organisations grapple with is data, and visibility across processes. Commonly…
Industries from retail to financial services have long accepted the need to digitally transform their operations. It paves the way for step changes in how brands operate, how they engage and get closer to customers, how they build market feedback into development cycles, how they drive new and repeat business, and how they identify and address new market opportunities.All of these challenges exist in the pharma industry too, so it seems surprising that companies here haven’t embraced the trend more enthusiastically.One of the biggest issues life sciences organisations grapple with is data, and visibility across processes. Commonly…
